GALT icon

Galectin Therapeutics

71 hedge funds and large institutions have $26.9M invested in Galectin Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

50% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 26

Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$648K
Puts
$255K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.68M
2
$4.94M
3
$2.77M
4
$2.28M
5
$1.86M
6
$1.59M
7
$1.25M
8
$510K
9
$493K
10
$486K
11
$347K
12
$325K
13
$296K
14
$283K
15
$229K
16
$197K
17
$181K
18
$169K
19
$153K
20
$114K
21
$111K
22
$101K
23
$85K
24
$76K
25
$74K